- ►diabetesjournals.org AJM Boulton, AI Vinik, JC Arezzo, V Bril, EL … - Diabetes Care, 2005 - Am Diabetes Assoc The diabetic neuropathies are heterogeneous, affecting different parts of the
nervous system that present with diverse clinical manifestations. They may be
focal or diffuse. Most common among the neuropathies are chronic ... Cited by 337 - Related articles - All 11 versions
- ►diabetesjournals.org AJM Boulton, RA Malik, JC Arezzo, JM … - Diabetes Care, 2004 - Am Diabetes Assoc The neuropathies are among the most common of the long-term complications of
diabetes, affecting up to 50% of patients (1–4). Their clinical features vary
immensely, and patients may present to a wide spectrum of specialties, from ... Cited by 222 - Related articles - BL Direct - All 6 versions
MA Cotter, K Ekberg, J Wahren, NE Cameron - Diabetes, 2003 - Am Diabetes Assoc Proinsulin C-peptide treatment can partially prevent nerve dysfunction in type 1
diabetic rats and patients. This could be due to a direct action on nerve fibers
or via vascular mechanisms as C-peptide stimulates the nitric oxide (NO) ... Cited by 51 - Related articles - BL Direct - All 4 versions
AAF Sima - eid, 2003 - informahealthcare.com 1. Introduction 2. The natural history of diabetic polyneuropathy in Type 1 and
Type 2 diabetes 3. Pathogenetic considerations in Type 1 and Type 2 diabetic
polyneuropathy 4. The effect of C-peptide on experimental Type 1 diabetic ... Cited by 45 - Related articles - All 4 versions
AAF Sima, W Zhang, ZG Li, Y Murakawa, CR … - Diabetes, 2004 - Am Diabetes Assoc To explore the molecular abnormalities underlying the degeneration of the node
of Ranvier, a characteristic aberration of type 1 diabetic neuropathy, we
examined in type 1 BB/Wor and type 2 BBZDR/Wor rats changes in expression ... Cited by 40 - Related articles - BL Direct - All 4 versions
CR Pierson, W Zhang, AAF Sima - Journal of Neuropathology & Experimental Neurology, 2003 - journals.lww.com We recently reported that early gene responses and expression of cytoskeletal
proteins are perturbed in regenerating nerve in type 1 insulinopenic diabetes
but not in type 2 hyperinsulinemic diabetes. We hypothesized that these ... Cited by 40 - Related articles - BL Direct - All 4 versions
Z Zhou, X Li, G Huang, J Peng, L Yang, X Yan … - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 36 - Related articles - All 3 versions
K Ekberg, T Brismar, BL Johansson, P … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—The age of the 139 patients who completed the protocol was 44.2 ± 0.6
(mean ± SE) years and their duration of diabetes was 30.6 ± 0.8 years.
Clinical neurological impairment (NIA) (score >7 points) of the lower ... Cited by 35 - Related articles - BL Direct - All 5 versions
H Kamiya, W Zhang, AAF Sima - Annals of neurology, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 33 - Related articles - BL Direct - All 3 versions
J Wahren - Clinical physiology and functional imaging, 2004 - interscience.wiley.com In contrast to earlier views, new data indicate that proinsulin C-peptide exerts
important physiological effects and shows the characteristics of an endogenous
peptide hormone. C-peptide in nanomolar concentrations binds specifically ... Cited by 30 - Related articles - BL Direct - All 5 versions
